RHT — Resonance Health Income Statement
0.000.00%
Last trade - 00:00- AU$16.10m
- AU$16.92m
- AU$11.16m
- 44
- 55
- 16
- 31
Annual income statement for Resonance Health, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 3.82 | 3.83 | 4.51 | 8.8 | 11.2 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 3.38 | 5.58 | 6.06 | 9.47 | 13 |
| Operating Profit | 0.432 | -1.74 | -1.55 | -0.665 | -1.84 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 0.344 | -1.55 | -1.26 | -0.627 | -2.2 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 0.586 | -1.14 | -0.78 | 0.169 | -1.73 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 0.586 | -1.14 | -0.78 | 0.169 | -1.73 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 0.586 | -1.14 | -0.78 | 0.169 | -1.73 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.001 | -0.003 | -0.002 | 0 | -0.004 |